Follow
Paolo Ghia
Paolo Ghia
Professor of Medical Oncology, Università Vita-Salute San Raffaele
Verified email at hsr.it - Homepage
Title
Cited by
Cited by
Year
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
RR Furman, JP Sharman, SE Coutre, BD Cheson, JM Pagel, P Hillmen, ...
New England Journal of Medicine 370 (11), 997-1007, 2014
21702014
Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
JA Burger, A Tedeschi, PM Barr, T Robak, C Owen, P Ghia, O Bairey, ...
New England Journal of Medicine 373 (25), 2425-2437, 2015
16912015
Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia
JC Byrd, B Harrington, S O’Brien, JA Jones, A Schuh, S Devereux, ...
New England Journal of Medicine 374 (4), 323-332, 2016
9902016
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Eichhorst, T Robak, E Montserrat, P Ghia, CU Niemann, AP Kater, ...
Annals of Oncology 32 (1), 23-33, 2021
8842021
Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial
K Fischer, J Bahlo, AM Fink, V Goede, CD Herling, P Cramer, ...
Blood, The Journal of the American Society of Hematology 127 (2), 208-215, 2016
7932016
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia
L Granziero, P Ghia, P Circosta, D Gottardi, G Strola, M Geuna, ...
Blood, The Journal of the American Society of Hematology 97 (9), 2777-2783, 2001
7192001
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
JA Burger, P Ghia, A Rosenwald, F Caligaris-Cappio
Blood, The Journal of the American Society of Hematology 114 (16), 3367-3375, 2009
6832009
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations
K Stamatopoulos, C Belessi, C Moreno, M Boudjograh, G Guida, ...
Blood 109 (1), 259-270, 2007
6642007
The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee
E Campo, ES Jaffe, JR Cook, L Quintanilla-Martinez, SH Swerdlow, ...
Blood, The Journal of the American Society of Hematology 140 (11), 1229-1253, 2022
6432022
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Y Herishanu, I Avivi, A Aharon, G Shefer, S Levi, Y Bronstein, M Morales, ...
Blood, The Journal of the American Society of Hematology 137 (23), 3165-3173, 2021
6062021
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase …
JP Sharman, M Egyed, W Jurczak, A Skarbnik, JM Pagel, IW Flinn, ...
The Lancet 395 (10232), 1278-1291, 2020
5882020
Diagnostic criteria for monoclonal B‐cell lymphocytosis
GE Marti, AC Rawstron, P Ghia, P Hillmen, RS Houlston, N Kay, ...
British journal of haematology 130 (3), 325-332, 2005
5262005
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
A Agathangelidis, N Darzentas, A Hadzidimitriou, X Brochet, F Murray, ...
Blood, The Journal of the American Society of Hematology 119 (19), 4467-4475, 2012
5082012
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia
AC Rawstron, N Villamor, M Ritgen, S Böttcher, P Ghia, JL Zehnder, ...
Leukemia 21 (5), 956-964, 2007
4842007
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study
JA Burger, PM Barr, T Robak, C Owen, P Ghia, A Tedeschi, O Bairey, ...
Leukemia 34 (3), 787-798, 2020
4712020
B-cell clones as early markers for chronic lymphocytic leukemia
O Landgren, M Albitar, W Ma, F Abbasi, RB Hayes, P Ghia, GE Marti, ...
New England Journal of Medicine 360 (7), 659-667, 2009
4262009
Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis
F Murray, N Darzentas, A Hadzidimitriou, G Tobin, M Boudjogra, ...
Blood, The Journal of the American Society of Hematology 111 (3), 1524-1533, 2008
4142008
Acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia: results of the first randomized phase III trial
JC Byrd, P Hillmen, P Ghia, AP Kater, A Chanan-Khan, RR Furman, ...
Journal of clinical oncology 39 (31), 3441, 2021
3812021
Recurrent mutations refine prognosis in chronic lymphocytic leukemia
P Baliakas, A Hadzidimitriou, LA Sutton, D Rossi, E Minga, N Villamor, ...
Leukemia 29 (2), 329-336, 2015
3802015
Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22
P Ghia, G Strola, L Granziero, M Geuna, G Guida, F Sallusto, N Ruffing, ...
European journal of immunology 32 (5), 1403-1413, 2002
3612002
The system can't perform the operation now. Try again later.
Articles 1–20